US Stock MarketDetailed Quotes
CYTH Cyclo Therapeutics
- 0.760
- +0.038+5.32%
Trading Nov 4 11:44 ET
21.81MMarket Cap-926P/E (TTM)
0.767High0.712Low6.10KVolume0.712Open0.722Pre Close4.55KTurnover0.04%Turnover RatioLossP/E (Static)28.70MShares2.11552wk High-4.25P/B12.07MFloat Cap0.59552wk Low--Dividend TTM15.88MShs Float17.750Historical High--Div YieldTTM7.62%Amplitude0.595Historical Low0.744Avg Price1Lot Size
About Cyclo Therapeutics Company
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
Company Profile
SymbolCYTH
Company NameCyclo Therapeutics
Listing DateDec 9, 2020
Founded1990
CEOMr. N. Scott Fine
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address6714 NW 16th Street,Suite B
CityGainesville
ProvinceFlorida
CountryUnited States of America
Zip Code32653
Phone1-386-418-8060
Company Executives
- Name
- Position
- Salary
- N. Scott Fine
- Director and Chief Executive Officer
- 672.89K
- Michael Lisjak
- Chief Regulatory Officer and Senior Vice President, Business Development
- 473.21K
- Joshua M. Fine
- Chief Financial Officer, Principal Accounting Officer and Secretary
- 463.98K
- Dr. Jeffrey L. Tate, PhD
- Director and Chief Operating Officer
- --
- Markus W. Sieger
- Chairman of the Board
- 66.38K
- F. Patrick Ostronic
- Vice Chairman of the Board
- 41.25K
- William Conkling
- Independent Director
- 13.33K
- C.E. Rick Strattan
- Independent Director
- 33.00K
- Dr. Randall M. Toig
- Independent Director
- 35.63K
- Shawn Cross
- Independent Director
- --
- Dr. Vivien Wong, PhD
- Independent Director
- 3.33K
- William S. Shanahan
- Independent Director
- 40.13K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data